CLOSE
CLOSE

Current Research Projects

Glaucoma Research Society of Canada grants $227,557.00 to 13 Research Projects in 2025:

(Researchers looking for GRSC’s online portal can click here) 

  • Lawson Health Research Institute, London, ON  – Novel Targeted Strategy for Enhanced Wound Modulation of Bleb-Forming Glaucoma Surgery, Dr. Cindy Hutnik, Dr. John F. Trant, Dr. Lisa Porter
  • Nova Scotia Health, Halifax, NS – Evaluation of the Accuracy and Reproducibility of Visual Field Testing Using a Virtual Reality Head-Mounted Device for Patients with Early, Moderate, and Severe Glaucoma, Reann Post, Dr. Brennan Eadi
  • The Governing Council of The University of Toronto, Toronto, ON – A Novel Approach to Promote Regeneration of the Optic Nerve, Liliana Attisano, Dr. Philippe Monnier
  • University Health Network, Toronto, ON – Biometric Predictors for Laser Peripheral Iridotomy: A Systematic Review and Meta-Analysis, Andrew Mihalache, Patrick Ji, Dr. Michael Balas, Dr. David Mathew
  • Nova Scotia Health, Halifax, NS – Comparison of Impact of Diabetic Macular Edema on the Neuroretinal Rim and Retinal Nerve Fiber Layer in Glaucoma, Sung Uk Baik, Dr. Balwantray Chauhan
  • Prism Eye Institute Inc., Brampton, ON – Glaucoma Medication Adherence and Persistence Rates in Ontario (Renewal), Matthew Schlenker, Dr. Ellen Tianwei Zhou
  • Prism Eye Institute Inc., Brampton, ON – Predicting Visual Field Progression in Glaucoma Using Machine Learning, Shayaan Kaleem, Dr. Matthew Schlenker
  • Nova Scotia Health, Halifax, NS – Comparison of the Safety and Efficacy of PreserFlo MicroShunt Alone versus with Amniotic Membrane in Glaucoma Surgery, Lesya Shuba, Gurkaran Sarohia, Dr. Marcelo Nicolela, Dr. Brennan Eadie, Devin Betsch
  • The Governing Council of The University of Toronto, Toronto, ON – Age at First Glaucoma Diagnosis and Medication Use in Canada: Findings from the Canadian Health Measures Survey, Dr. Yaping Jin, Dr. Dr. Yvonne Buys, Dr. Ziad Butty
  • Lawson Health Research Institute, London, ON – Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers: A Feasibility Randomized Controlled Trial (Renewal), Monali Malvankar, Dr. Cindy M. Hutnik
  • University Health Network, Toronto, ON – Quantifying Ocular Surface Disease with Preserved vs. Preservative-Free Prostaglandin Analogue Drops, Xiang (Patrick) Ji, Xiaole Li, Andrew Mihalache, Dr. Michael Balas, Dr. David Mathew
  • University of British Columbia, Vancouver, BC – Mast Cells as immune Activators in Glaucoma. Dr. Neeru Gupta, Dr. Yeni Yucel
  • Lawson Health Research Institute, London, ON – Impact of Breathing Exercises and Meditation on Improving Quality of Life in Glaucoma Patients: An Electronic Feasibility Study (Renewal), Monali Malvankar, Dr. Cindy M. Hutnik